ABVX (Abivax Pharma) Short-Term Debt to Capital
The market dynamics of ABIVAX (ABVX) reflected in the price action demonstrate the 0.00 indicator. Shareholder confidence is based on successful tests of new drugs. The business is not subject to economic cycles or seasonality, and the primary threats are linked solely to research results. ABIVAX attracts leading immunologists by providing them with extensive resources to create breakthrough therapies for inflammatory processes.
Analytical breakdowns for ABIVAX
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:abivax.com
ABIVAX ensures strict adherence to temperature regimes and logistics during innovative drug trials, which requires high financial stability. An analysis of short-term loan-to-capital history allows for an assessment of the share of current liabilities within the equity structure, revealing leverage dynamics and helping investors determine the intrinsic value of the business while avoiding the misconception that low debt indicates a lack of development.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ADMA (ADMA Biologics)|Short-Term Debt to Capital protagonist-inc.com PTGX|IMVT - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Short-Term Debt to Capital|Short-Term Debt to Capital auriniapharma.com|Short-Term Debt to Equity Ratio BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital DNTH (Dianthus Pharma)|Short-Term Debt to Capital Coefficient Pharvaris Pharma (PHVS)|ABCL - Short-Term Debt to Equity|tourmalinebio.com (TRML) - Short-Term Debt to Equity Ratio|Precigen (PGEN) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharming Group NV|Short-Term Debt to Equity Ratio NKTR|Short-Term Debt to Capital Upstream Pharma|Short-Term Debt to Equity Zenas Biopharma Inc (ZBIO)|immunome.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Current Liabilities to Capital|Septerna Corp - Short-Term Debt to Capital|PVLA - Short-Term Debt to Capital|SVRA: Short-Term Debt to Capital|RIGL (rigel.com) - Short-Term Debt to Equity|ANAB (AnaptysBio) - Short-Term Debt to Capital|Astria Therapeutics Inc (ATXS) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio ENGN (enGene Bio)|Short-Term Debt to Equity RAPT (rapt.com)|Short-Term Debt to Capital JBIO (Aerovate Therapeutics)|Short-Term Debt to Capital aclaristx.com ACRS|KYTX: Short-Term Debt to Equity Ratio|TLSA (Tiziana Life Sciences Ltd.) - Short-Term Debt to Capital Ratio|CABA: Short-Term Debt to Capital|Ventyx Biosciences, Inc (VTYX) - Short-Term Debt to Capital|THTX (Theratechnologies Inc.) - Short-Term Debt to Capital|Short-Term Debt to Equity AVTX|Short-Term Debt to Equity Ratio ELDN (Eledon Pharmaceuticals, Inc.)|Short-Term Debt to Equity AGEN (Agenus, Inc.)|Climb Bio, Inc. - Short-Term Debt to Equity Ratio|ZURA: Short-Term Debt to Capital Ratio|ATYR - Short-Term Debt to Equity|Current Liabilities to Equity ADAG|IMA: Short-Term Debt to Capital|Shattuck Labs - Ratio of Short-Term Indebtedness to Capital|EQ (Equillium Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital Connect Pharma|Short-Term Debt to Equity Immunic, Inc. (IMUX)|ATRA (atarabio.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity InflaRx IFRX|XFOR - Short-Term Debt to Equity Ratio|Adicet - Short-Term Debt to Capital|CELU - Short-Term Debt to Capital|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|barinthusbio.com - Ratio of Short-Term Indebtedness to Capital|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|SAB Biotherapeutics Inc. (SABS) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|Short-Term Debt to Equity Ratio enlivex.com ENLV|Short-Term Debt to Equity Q32 Bio QTTB|GOVX - Short-Term Debt to Equity Ratio|EDSA: Short-Term Debt to Equity Ratio|IBIO - Short-Term Debt to Capital|carismatx.com (CARM) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio XTLB|BOLT (Bolt Biotherapeutics Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital HCW Biologics Inc HCWB|Short-Term Debt to Capital APVO|Short-Term Debt to Capital aimimmuno.com (AIM)|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|GRI Bio Corporation - Short-Term Debt to Equity|XORTX Therapeutics Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient reshapelifesciences.com HIND|REVB (Revelation Biosciences, Inc.) - Short-Term Debt to Equity Ratio|INDP (Indaptus Therapeutics Inc) - Short-Term Debt to Equity|SCNI (Scinai) - Short-Term Debt to Capital|Short-Term Debt to Capital CalciMedica Corp|Short-Term Debt to Equity Ratio AFMD (Affimed)|allakos.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|iTeos - Short-Term Debt to Capital|OCEA: Short-Term Debt to Equity|TCBP (TC Biopharm) - Short-Term Debt to Equity Ratio|THRD (thirdharmonicbio.com) - Short-Term Debt to Equity